Clinical Trial Update: An Efficacy and Safety Study of Galantamine for the Treatment of Patients With Alzheimer's Disease. [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of galantamine in patients with Alzheimer's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Galantamine (galantamine)

Snippet

Sponsor: Janssen Pharmaceutical K.K. | Conditions: Alzheimer Disease | Phase 3 | Status: COMPLETED